Aimee Raleigh
InvestorPrincipal at Atlas Venture
Boston, Massachusetts
Writes $10M – $50M checks · typically $25M
About
Aimee Raleigh is a principal at Atlas Venture, where she works with founders building companies in therapeutics and biology. Before Atlas, she was a life sciences consultant at L.E.K. Consulting, advising pharmaceutical and biotech clients on strategy for early-stage therapies, asset diligence, and commercial planning. She holds a Ph.D. in bioengineering from the University of California, San Diego, and a B.S.E. in biomedical engineering from Duke University.
Invests in
Biotech
Experience
- Atlas VenturePrincipalcurrent2023 — presentBoston, Massachusetts, United States
- Atlas VentureSenior Associate2022 — 2023Boston, Massachusetts, United States
- Atlas VentureAssociate2020 — 2022Boston, Massachusetts, United States
- L.E.K. ConsultingLife Sciences Consultant2020
- L.E.K. ConsultingSenior Life Sciences Specialist2019 — 2020Los Angeles, California, United States
- L.E.K. ConsultingLife Sciences Specialist2018 — 2019Los Angeles, CA
- Cartilage Tissue Engineering Lab, UC San Diego Department of BioengineeringGraduate Researcher2013 — 2018La Jolla, California
- LuxSano BiomedCo-Founder2012 — 2014Durham, NC
- Headwater Partners, LLCInnovation Associate2013
- Duke UniversityUndergraduate Researcher in the Reichert Lab2012 — 2013
- Agilent TechnologiesMolecular Separations Intern2012Santa Clara, California
- Agilent TechnologiesLC/MS Intern2011Santa Clara, California
- Headwater Partners, LLCIntern2010
- DemandReportsIntern2009
Education
- UC San DiegoDoctor of Philosophy (Ph.D.), Bioengineering2015 — 2018
- UC San DiegoMaster’s Degree, Bioengineering2013 — 2015
- Duke UniversityBSE, Biomedical Engineering2009 — 2013
Skills & more
From Aimee's professional profile.
Same school
Also attended UC San Diego187
+ 181 more
Also attended Duke University384
+ 378 more
Shared employers
Also worked at Atlas Venture51
+ 45 more
Also worked at L.E.K. Consulting117
+ 111 more
Also worked at Duke University65
+ 59 more
Also worked at Agilent Technologies26
+ 20 more
Investments
Board seats
Aiolos BioKailera TherapeuticsRemix TherapeuticsTravin BioTriveni BioVersanis BioVima Therapeutics
Per the firm's website.
Colleagues at Atlas Venture
Network5
Investors connected to Aimee in public investor directories — a warm-intro map.
















.jpg)




















